Zotepine vs Haloperidol in Paranoid Schizophrenia: A Double-Blind Study;Zotepin vs. Haloperidol bei paranoider Schizophrenie: Eine Doppelblindstudie

Fortschritte der Neurologie Psychiatrie

Volumn 59, Issue , 1991, Pages 10-13

  Fleischhacker, W W ^a   Barnas, C ^a   Stuppack C H ^a   Sperner Unterweger, B ^a   Miller, C ^a   Hinterhuber, H ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; ZOTEPINE;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAPHY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PARANOIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIEPINS; DOUBLE-BLIND METHOD; DYSKINESIA, DRUG-INDUCED; FEMALE; HALOPERIDOL; HOSPITALIZATION; HUMANS; MALE; NEUROLOGIC EXAMINATION; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA, PARANOID;

EID: 0025883220     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-2007-1000728     Document Type: Article

References (21)

1. Amamoto, H., T. Goto: Clinical use of zotepine in schizophrenia. Clin. Rep. 14 (1980) 1660-1682.
2. American Psychiatric Association: DSM-III: Diagnostic and Statistical Manual of Mental Disorders. 3d ed. Washington (DC) 1980.
3. Arikawa, K., I. Yamauchi, H. Mukosa, A. Ishibashi, M. Matsuoka, T. Miura: Clinical experience with zotepine in schizophrenia. Jpn. J. Clin. Psychiatry 9 (1980) 653-666.
4. Dieterle, D. M., M. Ackenbeil, F. Múller-Spahn, H. P. Kapfhammer: Zotepine, a neuroleptic drug with a bipolar therapeutic profile. Pharmacopsychiatry 20 (Special Issue 1) (1987) 52-57.
5. Fleischhacker, W. W., B. Unterweger, C. Bamas, C. Stuppäck, H. Hinterhuber: Results of an open phase II study with zotepine. Pharmacopsychiatry 20 (Special Issue 1) (1987) 64-66.
6. Gärtner, H. J.: Klinische Pharmakologie der Neuroleptika. In: Langer, G., H. Heimann (eds.) : Psychopharmaka. Springer Verlag, New York - Wien 1983, pp. 243-244.
7. Guy, W. (ed.) : ECDEU Assessment Manual for Psychopharmacology, revised. DHEW Pub. No. (ADM) 76-338. MD: National Institute of Mental Health, Rockville 1976.
8. Harada, T., S. Otsuki: Antimanic effect of zotepine. Clin. Ther. 8 (1986) 406-414.
9. Harada, T., S. Otsuki, H. Ujike: Clinical and pharmacological studies on the antimanic effect of zotepine, a new neuroleptic drug. In: Proceedings of the 15th Collegium Internationale Neuro-Psycho-pharmacologicum Congress, San Juan, PR. (December 1986), pp. 328-329.
10. Kelly, D. M., R. J. Naylor: An intracerebral injection study on the role of striatal dopamine and 5-hydroxytryptamine in the production of tremor by harmine. Neuropharmacology 15 (1976) 303-308.
11. Lai, H., M. A. Carino, A. Horita: Antiserotonin properties of neuroleptic drugs. In: Yamamura, H.I., R.W. Olsen, E. Usdin (eds.) : Psychopharmacology and Biochemistry of Neurotransmitter Receptors. Elsevier-North Holland Biomedical Press, Amsterdam 1980, pp. 347-353.
12. Maj, J., J. Sarnek, V. Klimek, A. Rawlow: On the anticataleptic action of cyproheptadine. Pharmacol. Biochem. Behav. 5 (1976) 201-205.
13. National Institute of Mental Health: Clinical Global Impressions (CGI). In: Collegium Internationale Psychiatriae Scalarum (ed.) : Internationale Skalen fiir Psychiatrie. Beltz Test GmbH, Weinheim 1981.
14. Noda, K., A. Suzuki, M. Okui, H. Noguchi, M. Nishiura, N. Nishiura: Pharmacokinetics and metabolism of 2-chloro-ll- (2-dimethylami-noethoxy) -dibenzo[b,f]thiepine (zotepine) in rat, mouse, dog and man. Arzneimittel-Forsch./Drug Res. 29, 10 (1979) 1595-1600.
15. Overall, J. E., D. R. Gorham: Brief Psychiatric Rating Scale (BPRS). In: Collegium Internationale Psychiatriae Scalarum (ed.) : Internationale Skalen fúr Psychiatrie. Beltz Test GmbH, Weinheim 1981.
16. Sarai, K., M. Okada: Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study. Pharmacopsychiatry 20 (Special Issue 1) (1987) 38-46.
17. Shimomura, K., H. Satoh, O. Hirai, J. Mori, M. Tomoi, T. Terai, S. Katsuki, Y. Motoyama, T. Ono: The central anti-serotonin activity of zotepine, a new neuroleptic, in rats. Jap. J. Pharmacol. 32 (1982) 405-412.
18. Uchida, S., F. Honda, M. Otsuka, Y. Satoh, J. Mori, T. Orto, M. Hitomi: Pharmacological study of [2-chloro-ll- (2-dimethyl-aminoethoxy) dibenzo [b,f] thiepine] (zotepine), a new neuroleptic dnig. Arzneimittel-Forsch./Drug Res., 29 10 (1979) 1588-1594.
19. Uchitomi, Y., S. Yamawaki: Effects of zotepine on serotonin (5-HTi, 5-HT2) receptor function. Jap. J. Neuropsychopharmacol. 8 (1986) 315-322.
20. von Bardeleben, U., O. Benkert, F. Holsboer: Clinical and neuroendocrine effects of zotepine. Pharmacopsychiatry 20 (Special Issue 1) (1987) 28-34.
21. Yamawaki, S.: Profiles of clinical efficacy and pharmacological action of zotepine. Pharmacopsychiatry 20 (Special Issue 1) (1987) 4-7.